Back to User profile » Dr David Hollander

Papers published by Dr David Hollander:

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1)

Blinder KJ, Dugel PU, Chen S, Jumper JM, Walt JG, Hollander DA, Scott LC

Clinical Ophthalmology 2017, 11:393-401

Published Date: 21 February 2017

The IMPACT study: a prospective evaluation of the effects of cyclosporine ophthalmic emulsion 0.05% on ocular surface staining and visual performance in patients with dry eye

Stonecipher KG, Torkildsen GL, Ousler III GW, Morris S, Villanueva L, Hollander DA

Clinical Ophthalmology 2016, 10:887-895

Published Date: 13 May 2016

Effect of alcaftadine 0.25% on ocular itch associated with seasonal or perennial allergic conjunctivitis: a pooled analysis of two multicenter randomized clinical trials

Ciolino JB, McLaurin EB, Marsico NP, Ackerman SL, Williams JM, Villanueva L, Hollander DA

Clinical Ophthalmology 2015, 9:765-772

Published Date: 2 May 2015

Bimatoprost 0.01% or 0.03% in patients with glaucoma or ocular hypertension previously treated with latanoprost: two randomized 12-week trials

Myers JS, Vold S, Zaman F, Williams JM, Hollander DA

Clinical Ophthalmology 2014, 8:643-652

Published Date: 27 March 2014

Health claims database study of cyclosporine ophthalmic emulsion treatment patterns in dry eye patients

Stonecipher KG, Chia J, Onyenwenyi A, Villanueva L, Hollander DA

Therapeutics and Clinical Risk Management 2013, 9:409-415

Published Date: 25 October 2013

A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model

Ackerman S, D'Ambrosio, Jr F, Greiner JV, Villanueva L, Ciolino JB, Hollander DA

Journal of Asthma and Allergy 2013, 6:43-52

Published Date: 8 April 2013

PERSIST: Physician's Evaluation of Restasis® Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review

Mah F, Milner M, Yiu S, Donnenfeld E, Conway TM, Hollander DA

Clinical Ophthalmology 2012, 6:1971-1976

Published Date: 28 November 2012

Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits: response to authors

Chang-Lin J-E, Batoosingh AL, Hollander DA, Schiffman RM, Tang-Liu D D-S.

Clinical Ophthalmology 2011, 5:1119-1120

Published Date: 10 August 2011

Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost

Fechtner RD, Harasymowycz P, Nixon DR, Vold SD, Zaman F, Williams JM, Hollander DA

Clinical Ophthalmology 2011, 5:945-953

Published Date: 8 July 2011

Methicillin resistance of Staphylococcus species among health care and nonhealth care workers undergoing cataract surgery

Randall Olson, Eric Donnenfeld, Frank A Bucci Jr, et al

Clinical Ophthalmology 2010, 4:1505-1514

Published Date: 10 December 2010